Patient-Reported Outcome Measures Used in Temporomandibular Disorders: A Review of the Literature

Aims: To identify the range of patient-reported outcome measures (PROMs) used in TMD studies, summarize the available evidence for their psychometric properties, and provide guidance for the selection of such measures. Methods: A comprehensive search was conducted to retrieve articles published between 2009 and 2018 containing a patient-reported measure of the effects of TMDs. Three databases were searched: MEDLINE, Embase, and Web of Science. Results: A total of 517 articles containing at least one PROM were included in the review, and 57 additional studies were also located describing the psychometric properties of some tools in a TMD population. A total of 106 PROMs were identified and fell into the following categories: PROMs describing the severity of symptoms; PROMs describing psychologic status; and PROMs describing quality of life and general health. The most commonly used PROM was the visual analog scale. However, a wide range of verbal descriptors was employed. The Oral Health Impact Profile-14 and Beck Depression Inventory were the most commonly used PROMs describing the effect of TMDs on quality of life and psychologic status, respectively. Additionally, the Oral Health Impact Profile (various versions) and the Research Diagnostic Criteria Axis ll questionnaires were the instruments most repeatedly tested in a TMD population, and these instruments have undergone cross-cultural validation in several languages. Conclusion: A wide range of PROMs have been used to describe the impact of TMDs on patients. Such variability may limit the ability of researchers and clinicians to evaluate the efficacy of different treatments and make meaningful comparisons.

patient-reported outcome measures; psychometric properties; quality of life; review; temporomandibular disorders

1. de Leeuw Rd, Klasser GD, eds. American Academy of Orofacial Pain Guidelines for Assessment, Diagnosis, and Management, ed 5. Quintessence, 2013.

2. Durham J, Aggarwal V, Davies S, Harrison SD. Temporomandibular disorders (TMDs): An update and management guidance for primary care from the UK Specialist Interest Group in Orofacial Pain and TMDs (USOT). Royal College of Surgeons Faculty of Dental Surgery, 2013.

3. Murphy MK, MacBarb RF, Wong ME, Athanasiou KA. Temporomandibular disorders: A review of etiology, clinical management, and tissue engineering strategies. Int J Oral Maxillofac Implants 2013;28:e393–e414.

4. Durham J. Oral surgery: Part 3. Temporomandibular disorders. Br Dent J 2013;215:331–337.

5. Stohler CS. Muscle-related temporomandibular disorders. J Orofac Pain 1999;13:273–284.

6. Mills SEE, Nicolson KP, Smith BH. Chronic pain: A review of its epidemiology and associated factors in population-based studies. Br J Anaesth 2019;123:e273–e283.

7. Dworkin RH, Turk DC, Farrar JT, et al. Core outcome measures for chronic pain clinical trials: IMMPACT recommendations. Pain 2005;113:9–19.

8. Schiffman E, Ohrbach R, Truelove E, et al. Diagnostic criteria for temporomandibular disorders (DC/TMD) for clinical and research applications: Recommendations of the International RDC/TMD Consortium Network and Orofacial Pain Special Interest group. J Oral Facial Pain Headache 2014;28:6–27.

9. Jenkinson C, Coulter A, Bruster S. The picker patient experience questionnaire: Development and validation using data from in-patient surveys in five countries. Int J Qual Health Care 2002;14:353–358.

10. Jenkinson C, McGee HM. Health Status Measurement: A Brief But Critical Introduction. Radcliffe, 1998.

11. Griggs CL, Schneider JC, Kazis LE, Ryan CM. Patient-reported outcome measures: A stethoscope for the patient history. Ann Surg 2017;265:1066–1067.

12. Coons SJ, Rao S, Keininger DL, Hays RD. A comparative review of generic quality-of-life instruments. Pharmacoeconomics 2000;17:13–35.

13. Devlin NJ, Appleby J. Getting the most out of PROMs: Putting health outcomes at the heart of NHS decision-making. The King’s Fund, 2010.

14. Kluzek S, Dean B, Wartolowska KA. Patient-reported outcome measures (PROMs) as proof of treatment efficacy. BMJ Evid Based Med 2022;27:153–155.

15. Emerson AJ, MacPherson KL, Mischke JJ, Vendrely A. The psy-chometric properties of self-report outcome measures in temporomandibular dysfunction. Phys Ther Rev 2014;19:174–185.

16. Aguiar ADS, Nogueira Carrer HC, de Lira MR, Martins Silva GZ, Chaves TC. Patient-reported outcome measurements in temporomandibular disorders and headaches: Summary of measurement properties and applicability. J Clin Med 2021;10:3823.

17. Aitken RC. Measurement of feelings using visual analogue scales. Proc R Soc Med 1969;62:989–993.

18. Joyce CR, Zutshi DW, Hrubes V, Mason RM. Comparison of fixed interval and visual analogue scales for rating chronic pain. Eur J Clin Pharmacol 1975;8:415–420.

19. Huskisson EC. Measurement of pain. Lancet. 1974;2(7889): 1127–1131.

20. Ní Ríordáin R, Shirlaw P, Alajbeg I, et al. World workshop on oral medicine VI: Patient-reported outcome measures and oral mucosal disease: Current status and future direction. Oral Surg Oral Med Oral Pathol Oral Radiol 2015;120:152–160.e11.

21. Wiriyakijja P, Fedele S, Porter SR, Mercadante V, Ní Ríordáin R. Patient-reported outcome measures in oral lichen planus: A comprehensive review of the literature with focus on psychometric properties and interpretability. J Oral Pathol Med 2018;47:228–239.

22. Ní Ríordáin R, McCreary C. Patient-reported outcome measures in burning mouth syndrome—A review of the literature. Oral Dis 2013;19:230–235.

23. Hawker GA, Mian S, Kendzerska T, French M. Measures of adult pain: Visual analog scale for pain (VAS Pain), numeric rating scale for pain (NRS Pain), McGill pain questionnaire (MPQ), short-form McGill pain questionnaire (SF-MPQ), chronic pain grade scale (CPGS), short form-36 bodily pain scale (SF-36 BPS), and measure of intermittent and constant osteoarthritis pain (ICOAP). Arthritis Care Res (Hoboken) 2011;63(suppl 11):S240–S252.

24. Delgado DA, Lambert BS, Boutris N, et al. Validation of digital visual analog scale pain scoring with a traditional paper-based visual analog scale in adults. J Am Acad Orthop Surg Glob Res Rev 2018;2:e088.

25. Slade GD, Spencer AJ. Development and evaluation of the oral health impact profile. Community Dent Health 1994;11:3–11.

26. Mokkink LB, Prinsen CA, Patrick DL, et al. COSMIN methodology for systematic reviews of patient-reported outcome mea-sures (PROMs). COSMIN Manual for Systematic Reviews of PROMs. February 2018.

27. Durham J, Steele JG, Wassell RW, et al. Creating a patient- based condition-specific outcome measure for temporoman-dibular disorders (TMDs): Oral health impact profile for TMDs (OHIP-TMDs). J Oral Rehabil 2011;38:871–883.

28. Yule PL, Durham J, Playford H, et al. OHIP-TMDs: A patient- reported outcome measure for temporomandibular disorders. Community Dent Oral Epidemiol 2015;43:461–470.

29. Dijkers M. Measuring quality of life: Methodological issues. Am J Phys Med Rehabil 1999;78:286–300.

30. Allen PF, McMillan AS, Walshaw D, Locker D. A comparison of the validity of generic- and disease-specific measures in the assessment of oral health-related quality of life. Community Dent Oral Epidemiol 1999;27:344–352.

31. Dworkin SF, LeResche L. Research diagnostic criteria for temporomandibular disorders: Review, criteria, examinations and specifications, critique. J Craniomandib Disord 1992;6:301–355.

32. Ferreira NDR, Marto CMM, de Oliveira AT, Rodrigues MJ, DosSantos MF. Development of core outcome sets for clinical trials in temporomandibular disorders: A study protocol. PLoS One 2022;17:e0267722.

33. Loh SY, McLeod RWJ, Elhassan HA. Trismus following different treatment modalities for head and neck cancer: A systematic review of subjective measures. Eur Arch Otorhinolaryngol 2017;274:2695–2707.

34. Chiarotto A, Viti C, Sulli A, Cutolo M, Testa M, Piscitelli D. Cross-cultural adaptation and validity of the Italian version of the central sensitization inventory. Musculoskelet Sci Pract 2018;37:20–28.

35. Wang M, He S, Ji P. Validation of the centrality of pain scale in Chinese-speaking patients with painful temporomandibular disorders. Pain Med 2019;20:840–845.

36. Barbosa TS, Leme MS, Castelo PM, Gavião MB. Evaluating oral health-related quality of life measure for children and preadolescents with temporomandibular disorder. Health Qual Life Outcomes 2011;9:32.

37. La Touche R, Pardo-Montero J, Gil-Martínez A, et al. Craniofacial pain and disability inventory (CF-PDI): Development and psy-chometric validation of a new questionnaire. Pain Physician 2014;17:95–108.

38. Greghi SM, Dos Santos Aguiar A, Bataglion C, Ferracini GN, La Touche R, Chaves TC. Brazilian Portuguese version of the craniofacial pain and disability inventory: Cross-cultural reliability, internal consistency, and construct and structural validity. J Oral Facial Pain Headache 2018;32:389–399.

39. Durham J, Steele JG, Breckons M, Story W, Vale L. DEEP study: Does EQ-5D-5L measure the impacts of persistent oro-facial pain? J Oral Rehabil 2015;42:643–650.

40. Rodrigues-Bigaton D, de Castro EM, Pires PF. Factor and Rasch analysis of the Fonseca anamnestic index for the diag-nosis of myogenous temporomandibular disorder. Braz J Phys Ther 2017;21:120–126.

41. Campos JADB, Carrascosa AC, Bonafé FSS, Maroco J. Severity of temporomandibular disorders in women: Validity and reliability of the Fonseca anamnestic index. Braz Oral Res 2014;28:16–21.

42. Balik A, Peker K, Ozdemir-Karatas M. Comparisons of measures that evaluate oral and general health quality of life in patients with temporomandibular disorder and chronic pain. Cranio 2019;39:310–320.

43. Ohrbach R, Larsson P, List T. The jaw functional limitation scale: Development, reliability, and validity of 8-item and 20-item ver-sions. J Orofac Pain 2008;22:219–230.

44. Ohrbach R, Granger C, List T, Dworkin S. Preliminary development and validation of the jaw functional limitation scale. Community Dent Oral Epidemiol 2008;36:228–236.

45. Undt G, Murakami K-I, Clark GT, et al. Cross-cultural adap-tation of the JPF-Questionnaire for German-speaking patients with functional temporomandibular joint disorders. J Craniomaxillofac Surg 2006;34:226–233.

46. Aggarwal VR, Lunt M, Zakrzewska JM, Macfarlane GJ, Macfarlane TV. Development and validation of the manchester orofacial pain disability scale. Community Dent Oral Epidemiol 2005;33:141–149.

47. Kallás MS, Crosato EM, Biazevic MGH, Mori M, Aggarwal VR. Translation and cross-cultural adaptation of the manchester orofacial pain disability scale. J Oral Maxillofac Res 2013;3:e3.

48. Stegenga B, de Bont LG, de Leeuw R, Boering G. Assessment of mandibular function impairment associated with temporo-mandibular joint osteoarthrosis and internal derangement. J Orofac Pain 1993;7:183–195.

49. Xu L, Cai B, Fang Z. Translation and validation of a Chinese version of the mandibular function impairment questionnaire. J Oral Rehabil 2016;43:608–614.

50. Campos JADB, Carrascosa AC, Maroco J. Validity and reliability of the Portuguese version of mandibular function impairment questionnaire. J Oral Rehabil 2012;39:377–383.

51. Andreu Y, Galdon MJ, Durá E, et al. An examination of the psychometric structure of the multidimensional pain inventory in temporomandibular disorder patients: A confirmatory factor analysis. Head Face Med 2006;2:48.

52. Zucoloto ML, Maroco J, Duarte Bonini Campos JA. Psychometric properties of the multidimensional pain inventory applied to Brazilian patients with orofacial pain. J Oral Facial Pain Headache 2015;29:363–369.

53. Barbosa C, Manso MC, Reis T, Soares T, Gavinha S, Ohrbach R. Cultural equivalence, reliability and utility of the Portuguese version of the oral behaviours checklist. J Oral Rehabil 2018;45:924–931.

54. van der Meulen MJ, Lobbezoo F, Aartman IHA, Naeije M. Validity of the oral behaviours checklist: Correlations between OBC scores and intensity of facial pain. J Oral Rehabil 2014;41:115–121.

55. John MT, Patrick DL, Slade GD. The German version of the oral health impact profile—Translation and psychometric properties. Eur J Oral Sci 2002;110:425–433.

56. John MT, Miglioretti DL, LeResche L, Koepsell TD, Hujoel P, Micheelis W. German short forms of the oral health impact profile. Community Dent Oral Epidemiol 2006;34:277–288.

57. Larsson P, List T, Lundström I, Marcusson A, Ohrbach R. Reliability and validity of a Swedish version of the oral health impact profile (OHIP-S). Acta Odontol Scand 2004;62:147–152.

58. Segù M, Collesano V, Lobbia S, Rezzani C. Cross-cultural validation of a short form of the oral health impact profile for temporomandibular disorders. Community Dent Oral Epidemiol 2005;33:125–130.

59. van der Meulen MJ, John MT, Naeije M, Lobbezoo F. Developing abbreviated OHIP versions for use with TMD patients. J Oral Rehabil 2012;39:18–27.

60. Murray H, Locker D, Mock D, Tenenbaum HC. Pain and the quality of life in patients referred to a craniofacial pain unit. J Orofac Pain 1996;10:316–323.

61. He S-L, Wang J-H. Validation of the Chinese version of the oral health impact profile for TMDs (OHIP-TMDs-C). Med Oral Patol Oral Cir Bucal 2015;20:e161–e166.

62. Bush FM, Harkins SW. Pain-related limitation in activities of daily living in patients with chronic orofacial pain: Psychometric properties of a disability index. J Orofac Pain 1995;9:57–63.

63. Sugisaki M, Kino K, Yoshida N, Ishikawa T, Amagasa T, Haketa T. Development of a new questionnaire to assess pain-related limitations of daily functions in Japanese patients with temporomandibular disorders. Community Dent Oral Epidemiol 2005;33:384–395.

64. He SL, Wang JH, Ji P. Validation of the pain resilience scale in Chinese-speaking patients with temporomandibular disorders pain. J Oral Rehabil 2018;45:191–197.

65. Flor H, Behle DJ, Birbaumer N. Assessment of pain-re-lated cognitions in chronic pain patients. Behav Res Ther 1993;31:63–73.

66. Rener-Sitar K, John MT, Bandyopadhyay D, Howell MJ, Schiffman EL. Exploration of dimensionality and psychometric properties of the Pittsburgh sleep quality index in cases with temporomandibular disorders. Health Qual Life Outcomes 2014;12:10.

67. Streffer M-L, Büchi S, Mörgeli H, Galli U, Ettlin D. PRISM (pictorial representation of illness and self measure): A novel visual instrument to assess pain and suffering in orofacial pain pa-tients. J Orofac Pain 2009;23:140–146.

68. Lima-Verde AC, Pozza DH, Rodrigues LLFR, Velly AM, Guimarães AS. Cross-cultural adaptation and validation for Portuguese (Brazilian) of the pictorial representation of illness and self measure instrument in orofacial pain patients. J Orofac Pain 2013;27:271–275.

69. de Felicio CM, Melchior MdO, Da Silva MAM. Clinical validity of the protocol for multi-professional centers for the determination of signs and symptoms of temporomandibular disorders. Part II. Cranio 2009;27:62–67.

70. Dworkin SF, Sherman J, Mancl L, Ohrbach R, LeResche L, Truelove E. Reliability, validity, and clinical utility of the research diagnostic criteria for temporomandibular disorders axis II scales: Depression, non-specific physical symptoms, and graded chronic pain. J Orofac Pain 2002;16:207–220.

71. Ohrbach R, Turner JA, Sherman JJ, et al. The research diag-nostic criteria for temporomandibular disorders. IV: Evaluation of psychometric properties of the axis II measures. J Orofac Pain 2010;24:48–62.

72. de Lucena LBS, Kosminsky M, da Costa LJ, de Góes PS. Validation of the Portuguese version of the RDC/TMD axis II questionnaire. Braz Oral Res 2006;20:312–317.

73. John MT, Hirsch C, Reiber T, Dworkin SF. Translating the research diagnostic criteria for temporomandibular disorders into German: Evaluation of content and process. J Orofac Pain 2006;20:43–52.

74. Khoo S-P, Yap AUJ, Chan YH, Bulgiba AM. Translating the research diagnostic criteria for temporomandibular disorders into Malay: Evaluation of content and process. J Orofac Pain 2008;22:131–138.

75. Cavalcanti RF, Studart LM, Kosminsky M, de Goes PSA. Validation of the multimedia version of the RDC/TMD axis II questionnaire in Portuguese. J Appl Oral 2010;18:231–236.

76. Shedden Mora MC, Weber D, Neff A, Rief W. Biofeedback-based cognitive-behavioral treatment compared with occlusal splint for temporomandibular disorder: A randomized controlled trial. Clin J Pain 2013;29:1057–1065.77. Dias IM, Bastos RR, Alves RT, Leite ICG. Construction and validation of an questionnaire for evaluating self-medication practised by patients with temporomandibular disorders. J Oral Rehabil 2019;46:424–432.

78. Deli R, Macrì LA, Mannocci A, La Torre G. Measuring quality of life in TMD: Use of SF-36. Italian J Public Health 2009;6. doi: https://doi.org/10.2427/5790

79. He S, Wang J. Validation of the social support and pain questionnaire (SPQ) in patients with painful temporomandibular disorders. J Headache Pain 2017;18:57.

80. Funch DP, Marshall JR, Gebhardt GP. Assessment of a short scale to measure social support. Soc Sci Med 1986;23:337–344.

81. Nixdorf DR, John MT, Wall MM, Fricton JR, Schiffman EL. Psychometric properties of the modified symptom severity index (SSI). J Oral Rehabil 2010;37:11–20.

82. Visscher CM, Ohrbach R, van Wijk AJ, Wilkosz M, Naeije M. The Tampa scale for kinesiophobia for temporomandibular disorders (TSK-TMD). Pain 2010;150:492–500.

83. He SL, Wang JH, Ji P. Validation of the Tampa scale for kinesio-phobia for temporomandibular disorders (TSK-TMD) in patients with painful TMD. J Headache Pain 2016;17:109.

84. Aguiar AS, Bataglion C, Visscher CM, Bevilaqua Grossi D, Chaves TC. Cross-cultural adaptation, reliability and construct validity of the Tampa scale for kinesiophobia for temporoman-dibular disorders (TSK/TMD-Br) into Brazilian Portuguese. J Oral Rehabil 2017;44:500–510.

85. Gonzalez YM, Schiffman E, Gordon SM, et al. Development of a brief and effective temporomandibular disorder pain screening questionnaire: Reliability and validity. J Am Dent Assoc 2011;142:1183–1191.

86. Rollman A, Naeije M, Visscher CM. The reproducibility and re-sponsiveness of a patient-specific approach: A new instrument in evaluation of treatment of temporomandibular disorders. J Orofac Pain 2010;24:101–105.

87. Ismail F, Lange K, Gillig M, et al. WHO-5 well-being index as screening instrument for psychological comorbidity in patients with temporomandibular disorder. Cranio 2018;36:189–194.